Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 96

1.

Nonsynonymous variants in the SMAD6 gene predispose to congenital cardiovascular malformation.

Tan HL, Glen E, Töpf A, Hall D, O'Sullivan JJ, Sneddon L, Wren C, Avery P, Lewis RJ, ten Dijke P, Arthur HM, Goodship JA, Keavney BD.

Hum Mutat. 2012 Apr;33(4):720-7. doi: 10.1002/humu.22030. Epub 2012 Feb 14.

2.

Bone morphogenetic protein activities are enhanced by 3',5'-cyclic adenosine monophosphate through suppression of Smad6 expression in osteoprogenitor cells.

Sugama R, Koike T, Imai Y, Nomura-Furuwatari C, Takaoka K.

Bone. 2006 Feb;38(2):206-14. Epub 2005 Oct 3.

PMID:
16203197
3.

Selective inhibitory effects of Smad6 on bone morphogenetic protein type I receptors.

Goto K, Kamiya Y, Imamura T, Miyazono K, Miyazawa K.

J Biol Chem. 2007 Jul 13;282(28):20603-11. Epub 2007 May 10.

4.

OAZ regulates bone morphogenetic protein signaling through Smad6 activation.

Ku M, Howard S, Ni W, Lagna G, Hata A.

J Biol Chem. 2006 Feb 24;281(8):5277-87. Epub 2005 Dec 22.

5.

Bone morphogenetic protein 2 activates Smad6 gene transcription through bone-specific transcription factor Runx2.

Wang Q, Wei X, Zhu T, Zhang M, Shen R, Xing L, O'Keefe RJ, Chen D.

J Biol Chem. 2007 Apr 6;282(14):10742-8. Epub 2007 Jan 10.

6.

Smad6 inhibits the transcriptional activity of Tbx6 by mediating its degradation.

Chen YL, Liu B, Zhou ZN, Hu RY, Fei C, Xie ZH, Ding X.

J Biol Chem. 2009 Aug 28;284(35):23481-90. doi: 10.1074/jbc.M109.007864. Epub 2009 Jun 26.

7.

Involvement of PRIP (Phospholipase C-Related But Catalytically Inactive Protein) in BMP-Induced Smad Signaling in Osteoblast Differentiation.

Kotani M, Matsuda M, Murakami A, Takahashi I, Katagiri T, Hirata M.

J Cell Biochem. 2015 Dec;116(12):2814-23. doi: 10.1002/jcb.25228.

PMID:
25981537
8.

Hoxc8 represses BMP-induced expression of Smad6.

Kang M, Bok J, Deocaris CC, Park HW, Kim MH.

Mol Cells. 2010 Jan;29(1):29-33. doi: 10.1007/s10059-010-0007-1. Epub 2009 Dec 7.

9.

Smad6 is a Smad1/5-induced smad inhibitor. Characterization of bone morphogenetic protein-responsive element in the mouse Smad6 promoter.

Ishida W, Hamamoto T, Kusanagi K, Yagi K, Kawabata M, Takehara K, Sampath TK, Kato M, Miyazono K.

J Biol Chem. 2000 Mar 3;275(9):6075-9.

10.

Identification and analysis of type II TGF-β receptors in BMP-9-induced osteogenic differentiation of C3H10T1/2 mesenchymal stem cells.

Wu N, Zhao Y, Yin Y, Zhang Y, Luo J.

Acta Biochim Biophys Sin (Shanghai). 2010 Oct;42(10):699-708. doi: 10.1093/abbs/gmq075. Epub 2010 Aug 27.

PMID:
20801928
11.

Investigating bone morphogenetic protein (BMP) signaling in a newly established human cell line expressing BMP receptor type II.

Kudo TA, Kanetaka H, Watanabe A, Okumoto A, Asano M, Zhang Y, Zhao F, Kano M, Shimizu Y, Tamura S, Hayashi H.

Tohoku J Exp Med. 2010 Oct;222(2):121-9.

12.

Dysregulated bone morphogenetic protein signaling in monocrotaline-induced pulmonary arterial hypertension.

Morty RE, Nejman B, Kwapiszewska G, Hecker M, Zakrzewicz A, Kouri FM, Peters DM, Dumitrascu R, Seeger W, Knaus P, Schermuly RT, Eickelberg O.

Arterioscler Thromb Vasc Biol. 2007 May;27(5):1072-8. Epub 2007 Mar 8.

13.

Inhibition of erythropoiesis by Smad6 in human cord blood hematopoietic stem cells.

Kang YJ, Shin JW, Yoon JH, Oh IH, Lee SP, Kim SY, Park SH, Mamura M.

Biochem Biophys Res Commun. 2012 Jul 13;423(4):750-6. doi: 10.1016/j.bbrc.2012.06.031. Epub 2012 Jun 15.

PMID:
22705548
14.
15.

Proteasome inhibitor MG-132 lowers gastric adenocarcinoma TMK1 cell proliferation via bone morphogenetic protein signaling.

Wu WK, Sung JJ, Yu L, Cho CH.

Biochem Biophys Res Commun. 2008 Jun 27;371(2):209-14. doi: 10.1016/j.bbrc.2008.04.059. Epub 2008 Apr 22.

PMID:
18435911
16.

Mutual regulation of follicle-stimulating hormone signaling and bone morphogenetic protein system in human granulosa cells.

Miyoshi T, Otsuka F, Suzuki J, Takeda M, Inagaki K, Kano Y, Otani H, Mimura Y, Ogura T, Makino H.

Biol Reprod. 2006 Jun;74(6):1073-82. Epub 2006 Jan 25.

PMID:
16436528
17.

Protective Role of Smad6 in Inflammation-Induced Valvular Cell Calcification.

Li X, Lim J, Lu J, Pedego TM, Demer L, Tintut Y.

J Cell Biochem. 2015 Oct;116(10):2354-64. doi: 10.1002/jcb.25186.

18.

Parathyroid hormone enhances bone morphogenetic protein activity by increasing intracellular 3', 5'-cyclic adenosine monophosphate accumulation in osteoblastic MC3T3-E1 cells.

Nakao Y, Koike T, Ohta Y, Manaka T, Imai Y, Takaoka K.

Bone. 2009 May;44(5):872-7. doi: 10.1016/j.bone.2009.01.370. Epub 2009 Jan 31.

PMID:
19442611
19.

CREB Cooperates with BMP-stimulated Smad signaling to enhance transcription of the Smad6 promoter.

Ionescu AM, Drissi H, Schwarz EM, Kato M, Puzas JE, McCance DJ, Rosier RN, Zuscik MJ, O'Keefe RJ.

J Cell Physiol. 2004 Mar;198(3):428-40.

PMID:
14755548
20.

Arginine Methylation Initiates BMP-Induced Smad Signaling.

Xu J, Wang AH, Oses-Prieto J, Makhijani K, Katsuno Y, Pei M, Yan L, Zheng YG, Burlingame A, Brückner K, Derynck R.

Mol Cell. 2013 Jul 11;51(1):5-19. doi: 10.1016/j.molcel.2013.05.004. Epub 2013 Jun 6.

Supplemental Content

Support Center